Transforming ADCs and Radiopharmaceuticals
Singzyme
Lower Toxicity and Cost effective Cancer Therapies Through Superior Conjugation Technology
About Us
Mission
At Singzyme, we are redefining how the world builds bioconjugates. Our mission is to enable the next generation of antibody-drug conjugates through precise, efficient, and scalable enzymatic ligation—bringing life-saving therapies to patients faster.
Vision
We envision a future where every bioconjugate is made smarter. Powered by our breakthrough peptide ligase platform, Singzyme is setting a new global standard in bioconjugation—where innovation meets impact.